Fritextsökning
Innehållstyper
-
Shaping regulatory complexity into strategic clarity
As AI continues to reshape healthcare, clear guidance on health data use is more critical than ever. Building on the success of the AI Act e-tool and the Data A...
-
Multiplex Immunofluorescence
New protocol for efficient generation of seven-color, whole slide imaging with ZEISS Axioscan.
-
Asgard lär tumören ta kål på sig själv – närmar sig klinisk prövning
Lundbaserade Asgard Therapeutics har inte bara ett fantasieggande namn, utan även en sällsynt spännande approach till cancerbekämpning: att få tumörceller att p...
-
Genovis i samarbetsavtal med nederländsk partner
Biotechbolaget Genovis har ingått ett partnerskap med nederländska Single Cell Discoveries för att möjliggöra storskaliga analyser av genuttryck.
-
New findings on the diseases that crushed Napoleon’s army
As if cold, starvation, and typhus weren’t enough. New research reveals that Napoleon’s defeated army also suffered from paratyphoid fever and relapsing fever d...
-
The Future of Metrology is Coming to Your Region
Join our event series.
-
Explore the latest trends and innovations in quality assurance and manufacturing
ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.
-
Could an overly burdensome QMS be the organization’s own doing?
Although the above statement is intentionally somewhat provocative, it does hold a degree of truth. Organizations that are generally negative toward regulations...
-
Sneak Peek of ZEISS Metrology Expert Tips Season 2
The second season of the video series starts in January 2026, but you can discover more about the highlights of Season 2 now.
-
1,6 nya Wallenbergmiljarder till life science
Svensk patientnära forskning tillförs 1,6 miljarder kronor. ”Det här är ett kraftfullt, långsiktigt initiativ för att svensk klinisk forskning inte ska tappa fa...
-
Genovis i licensavtal med amerikansk partner – ”En stark bekräftelse”
Skånebaserade Genovis har ingått ett licensavtal som kan ge bolaget upp till 20 miljoner dollar för varje program som når kommersialisering.
-
Nybildat råd ska stärka västsvensk life science
En rad ledande aktörer går ihop i ett gemensamt råd för att stärka Västsveriges life science-sektor.
-
Vaccine project targeting congenital infection scrapped in late-stage trial – “Clearly disappointed”
Hope for the first vaccine against the world’s most common congenital infection has taken a serious hit
-
Quality assurance for research and development of medical devices
Overcome the hurdles of research, development, and QA lab environments within the regulated medical technology industry.
-
Sex nya innovationsmiljöer ska utveckla precisionsmedicin
Vinnova anslår 95 miljoner kronor till sex nya innovationsmiljöer med inriktning på precisionmedicin.
-
OEM Automatic i samarbete med Schwer Fittings
OEM Automatic utökar sitt sortiment inom tryck- och flödesteknik genom ett nytt samarbete med den europeiska tillverkaren Schwer Fittings – specialister på kopp...
-
Canada approves leqembi as global alzheimer’s drug race heats up
Leqembi has secured approval in Canada, further consolidating its global lead among disease-modifying Alzheimer’s therapies. The antibody is now authorized in 1...
-
Integrated solutions for liquid handling
Greater efficiency for manufacturers in laboratory automation and many other industries
-
Carl Zeiss Meditec achieves revenue growth and stable operating profit
Further recovery in order entry compared to prior year.
-
Sarah Lidé: ”Artificial intelligence must not replace authentic interactions”
Artificial intelligence must never become a replacement for authentic, even if messy, interactions with our fellow humankind, Sarah Lifé, Deputy CEO at Medicon ...
-
Psykedelikabolag rusar på börsen efter Trumps besked
Aktier i bolag som utvecklar psykedeliska läkemedel rusade på måndagen efter att USA:s president Donald Trump i helgen undertecknat en order om snabbare granskn...
-
Gene therapy restored hearing in children with congenital deafness
Eleven out of twelve children with congenital deafness showed improvements in a study testing Regeneron’s gene therapy for hereditary hearing loss. The U.S. com...
-
Swedish life science is growing – but capital is not keeping up
The number of employees and companies in Swedish life science is increasing and the sector is more equal than many other sectors. But investments in unlisted co...
-
Improved processes and more
Discover the full potential and benefits.
BREAKING